Impact of cross-linking stoichiometry on the structure and allergenicity of glutaraldehyde-polymerized allergen extracts

交联化学计量对戊二醛聚合过敏原提取物的结构和致敏性的影响

阅读:2

Abstract

INTRODUCTION: Polymerized allergen extracts are widely used in allergen immunotherapy (AIT) to reduce allergenicity and enhance safety. However, the impact of cross-linking stoichiometry on the structural and allergenic properties of these polymers remains insufficiently characterized. This study systematically investigates how varying glutaraldehyde-to-protein ratios influence the resulting polymers and their potential relevance for AIT. METHODS: Pollen extracts from Phleum pratense and Betula verrucosa were polymerized using five different glutaraldehyde-to-protein ratios. The resulting polymers were structurally characterized using SDS-PAGE, nuclear magnetic resonance (NMR), transmission electron microscopy (TEM), and mass spectrometry (MS). Allergenicity was evaluated by measuring the immunoglobulin E (IgE) reactivity through enzyme-linked immunosorbent assay (ELISA), Western blotting, and mast cell activation test (MAT). Immunogenicity was assessed by analyzing the serum-specific IgG and ex vivo lymphocyte responses in mice immunized with the least allergenic polymer formulation. RESULTS: All cross-linking conditions produced polymers with distinct differences in size, morphology, and yield. Despite retaining similar peptide profiles to native allergens, as confirmed by MS, the polymers exhibited increased stability, as shown by NMR, and significantly reduced allergenicity, according to ELISA and MAT. Notably, increased polymer size and density, as determined by NMR and TEM, correlated with lower allergenicity. The most extensively cross-linked high-density polymers, optimized for minimal allergenicity, elicited immunogenic responses comparable to those induced by native extracts when tested against unmodified allergens. CONCLUSION: Cross-linking stoichiometry critically shapes the structural and immunological properties of polymerized allergen extracts. Adjusting the glutaraldehyde-to-protein ratio to produce highly polymerized, dense polymers enables a well-balanced profile of safety and efficacy for use in AIT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。